Avexa Limited
Records under this name other than patents Avexa Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Avexa Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,143,268 | Bicyclic pyrimidinones and uses thereof Lapsed on the fee record Ended Mar 27, 2020 · From the USPTO record | Lapsed on the fee record | Ended Mar 27, 2020 | From the USPTO record |
| US 8,859,563 | Bicyclic pyrimidinones and uses thereof Lapsed on the fee record Ended Oct 14, 2018 · From the USPTO record | Lapsed on the fee record | Ended Oct 14, 2018 | From the USPTO record |
| US 8,563,562 | Compounds having antiviral properties Lapsed on the fee record Ended Oct 22, 2017 · From the USPTO record | Lapsed on the fee record | Ended Oct 22, 2017 | From the USPTO record |
| US 8,431,581 | Imidazopyrimidines and uses thereof Lapsed on the fee record Ended Apr 30, 2017 · From the USPTO record | Lapsed on the fee record | Ended Apr 30, 2017 | From the USPTO record |
| US 8,426,405 | Thiazopyrimidinones and uses thereof Lapsed on the fee record Ended Apr 23, 2017 · From the USPTO record | Lapsed on the fee record | Ended Apr 23, 2017 | From the USPTO record |
| US 8,318,732 | Compounds having antiviral properties Lapsed on the fee record Ended Nov 27, 2016 · From the USPTO record | Lapsed on the fee record | Ended Nov 27, 2016 | From the USPTO record |
| US 8,318,934 | Process for chiral resolution of 2-substituted 4-substituted 1,3-oxathiolanes Lapsed on the fee record Ended Nov 27, 2016 · From the USPTO record | Lapsed on the fee record | Ended Nov 27, 2016 | From the USPTO record |
| US 8,207,334 | Bicyclic pyrimidinones and uses thereof Lapsed on the fee record Ended Jun 26, 2016 · From the USPTO record | Lapsed on the fee record | Ended Jun 26, 2016 | From the USPTO record |